Dietary supplementation with glucan enhances immune fn
膳食补充葡聚糖可增强免疫功能
基本信息
- 批准号:6534558
- 负责人:
- 金额:$ 15.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-09-10 至 2004-08-31
- 项目状态:已结题
- 来源:
- 关键词:Peyer's patches RNase protection assay Streptococcus pneumoniae bactericidal immunity blood chemistry dietary supplements flow cytometry folk medicine gel mobility shift assay glucans histochemistry /cytochemistry immunomodulators influenzavirus A laboratory mouse microorganism immunology nuclear factor kappa beta nutrition related tag oral administration polymerase chain reaction serology /serodiagnosis virus diseases
项目摘要
DESCRIPTION (APPLICANT'S ABSTRACT): Glucans are natural product polymers of
glucose, which are produced by fungi, certain bacteria and plants. Glucans have
demonstrated the ability to stimulate immunity and increase resistance to
infectious challenge following systemic administration, i.e., N, IP, IM or SQ.
As natural products, glucans are found as fiber in the normal diet.
Additionally, glucans have been identified as components of Chinese, Japanese
and Indian traditional medicines. Recently, several dietary supplements have
appeared on the market which are reported to contain glucan. The manufacturers
have inferred from the scientific literature that dietary supplementation with
glucans will have beneficial effects comparable to those observed with systemic
administration. The development of a dietary supplement which could increase
immunocompetence and enhance resistance to common infections would be of
significant benefit to human health. However, the evidence that dietary
supplementation with glucans will enhance immunity is limited and controversial
and there is no evidence that these supplements will increase resistance to
common infectious diseases. The objectives of this R21 exploratory research
program are to determine whether dietary supplementationwith glucan will
modulate immune function and, more importantly, whether oral glucans will
increase resistance to common infectious diseases. There are two specific aims.
First, we will characterize the local and systemic immunomodulation associated
with dietary supplementation of glucan. Second, we will determine whether oral
administration of (1--3)-(3-D-glucans will enhance resistance to challenge with
the respiratory pathogens, Streptococcus neumoniae or murine adapted influenza
A/PR8/34 HIM virus. At the successful conclusion of this research e will have
established what, if any, effect dietary supplementation with glucan has on
modulating immunocompetence arid whether oral glucans will increase resistance
to infectious diseases.
性状(申请人摘要):葡聚糖是天然产物聚合物,
葡萄糖,由真菌,某些细菌和植物产生。葡聚糖具有
证明了刺激免疫力和增加抵抗力的能力,
全身给药后的感染性激发,即,N、IP、IM或SQ。
作为天然产物,葡聚糖在正常饮食中以纤维形式存在。
此外,葡聚糖已被确定为中国、日本和美国的成分。
印度传统医药。最近,几种膳食补充剂
市场上出现的含有葡聚糖的产品。制造商
从科学文献中推断,
葡聚糖将具有与全身性
局开发一种膳食补充剂,
免疫活性和增强对常见感染的抵抗力将是
对人体健康有重大益处。然而,有证据表明,饮食
补充葡聚糖可增强免疫力是有限且有争议的
没有证据表明这些补充剂会增加抵抗力,
常见传染病。R21探索性研究的目的是
计划是确定饮食中添加葡聚糖是否会
调节免疫功能,更重要的是,
增强对常见传染病的抵抗力。有两个具体目标。
首先,我们将描述局部和全身免疫调节相关的
饮食中补充葡聚糖。第二,我们将确定是否口头
施用(1- 3)-(3-D-葡聚糖将增强对
呼吸道病原体,链球菌或鼠适应性流感
A/PR 8/34 HIM病毒。在这项研究的成功结束时,
确定饮食中补充葡聚糖对
调节免疫能力以及口服葡聚糖是否会增加抵抗力
传染性疾病。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Effect on physical functioning of care in adult foster homes and nursing homes.
成人寄养家庭和疗养院护理对身体功能的影响。
- DOI:10.1093/geront/35.5.648
- 发表时间:1995
- 期刊:
- 影响因子:0
- 作者:Stark,AJ;Kane,RL;Kane,RA;Finch,M
- 通讯作者:Finch,M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David L. Williams其他文献
IDENTIFICATION OF PHOSPHATE SUBSTITUTION SITES BY NMR SPECTROSCOPY IN A WATER-SOLUBLE PHOSPHORYLATED (13)-BETA -D-GLUCAN
通过核磁共振波谱法鉴定水溶性磷酸化 (13)-β-D-葡聚糖中的磷酸盐取代位点
- DOI:
- 发表时间:
1998 - 期刊:
- 影响因子:0
- 作者:
D. Lowman;H. Ensley;David L. Williams - 通讯作者:
David L. Williams
Disulfide Bridges in Tropomyosin
原肌球蛋白中的二硫桥
- DOI:
- 发表时间:
2005 - 期刊:
- 影响因子:0
- 作者:
David L. Williams;C. Swenson - 通讯作者:
C. Swenson
The rat and mouse eye
大鼠和小鼠的眼睛
- DOI:
10.1002/9781118709627.ch7 - 发表时间:
2013 - 期刊:
- 影响因子:5.2
- 作者:
David L. Williams - 通讯作者:
David L. Williams
Experience-dependent recovery of cognitive functioning in young alcoholics.
年轻酗酒者认知功能的经验依赖性恢复。
- DOI:
10.1016/0306-4603(85)90023-1 - 发表时间:
1985 - 期刊:
- 影响因子:4.4
- 作者:
M. Goldman;D. Klisz;David L. Williams - 通讯作者:
David L. Williams
Focusing Agricultural Education Research: An Agenda for the Graduate Student.
聚焦农业教育研究:研究生议程。
- DOI:
10.5032/jae.1997.03028 - 发表时间:
1997 - 期刊:
- 影响因子:0
- 作者:
David L. Williams - 通讯作者:
David L. Williams
David L. Williams的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David L. Williams', 18)}}的其他基金
Development of an alpha-1 phosphate mannan vaccine against the emerging fungal pathogen Candida auris.
开发针对新兴真菌病原体耳念珠菌的 α-1 磷酸甘露聚糖疫苗。
- 批准号:
10573467 - 财政年份:2023
- 资助金额:
$ 15.56万 - 项目类别:
Amelioration of Sepsis by Macrophage Activation
通过巨噬细胞激活改善脓毒症
- 批准号:
7939064 - 财政年份:2009
- 资助金额:
$ 15.56万 - 项目类别:
IMMUNE RECOGNITION OF CANDIDA--ROLE OF CELL WALL
念珠菌的免疫识别--细胞壁的作用
- 批准号:
6225237 - 财政年份:2001
- 资助金额:
$ 15.56万 - 项目类别:
Dietary supplementation with glucan enhances immune fn
膳食补充葡聚糖可增强免疫功能
- 批准号:
6317216 - 财政年份:2001
- 资助金额:
$ 15.56万 - 项目类别:
BIOMOLECULAR INTERACTION ANALYSIS INSTRUMENTATION
生物分子相互作用分析仪器
- 批准号:
2489127 - 财政年份:1998
- 资助金额:
$ 15.56万 - 项目类别:
Amelioration of Sepsis by Macrophage Activation
通过巨噬细胞激活改善脓毒症
- 批准号:
8235529 - 财政年份:1996
- 资助金额:
$ 15.56万 - 项目类别:
AMELIORATION OF SEPSIS BY MACROPHAGE ACTIVATION
通过巨噬细胞激活改善脓毒症
- 批准号:
6628698 - 财政年份:1996
- 资助金额:
$ 15.56万 - 项目类别:
Amelioration of Sepsis by Macrophage Activation
通过巨噬细胞激活改善脓毒症
- 批准号:
7281703 - 财政年份:1996
- 资助金额:
$ 15.56万 - 项目类别:
AMELIORATION OF SEPSIS BY MACROPHAGE ACTIVATION
通过巨噬细胞激活改善脓毒症
- 批准号:
2192894 - 财政年份:1996
- 资助金额:
$ 15.56万 - 项目类别:
AMELIORATION OF SEPSIS BY MACROPHAGE ACTIVATION
通过巨噬细胞激活改善脓毒症
- 批准号:
2685082 - 财政年份:1996
- 资助金额:
$ 15.56万 - 项目类别:
相似海外基金
NOVEL RNASE PROTECTION ASSAY FOR CYTOKINE MRNAS
细胞因子 MRNAS 的新型 RNA 酶保护测定
- 批准号:
6317727 - 财政年份:2000
- 资助金额:
$ 15.56万 - 项目类别: